Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with colorectal (bowel) or ovarian cancer, confirmed by a tissue sample (biopsy).
- Your cancer has spread, or is suspected to have spread, to the lining of the abdomen (the peritoneum).
- You are scheduled for surgery aimed at completely removing the cancer spread in the abdomen, possibly with chemotherapy beforehand.
- Your general health and ability to carry out daily activities meets a certain minimum level, as assessed by your doctor (confirm with trial site).
- You are willing and able to sign a consent form before any study-related checks begin.
Who may not be able to join:
- Your cancer has spread to areas outside the abdomen that cannot be surgically removed, or you have more than 3 spots of cancer on the liver.
- You have a long-term inflammatory condition, especially affecting the gut, such as inflammatory bowel disease or Crohn's disease.
- You are currently pregnant or breastfeeding.
- You have been diagnosed with another cancer within the last 3 years, unless it was an early-stage cervical cancer or a certain type of skin cancer that has already been fully treated.
- You have another serious health condition that, in your doctor's opinion, could affect your ability to complete the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patrick Flamen, Jules Bordet Institute
Phone: +32 (0) 2 541 37 81
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation of the Ga68-FAPI PET/CT derived PCI (peritoneal cancer index) score with the intraoperative PCI based on histopathology of resected specimen (the reference standard)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.